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Experimental autoimmune encephalomyelitis (EAE) is an animal 
model of multiple sclerosis, a prototype of Th1/Th17-mediated organ-specific 
autoimmune disease. In the rat, susceptibility to development of these diseases 
is shown to be strain- and age-dependent. In adult rats of distinct strains, it 
correlates with splenic dendritic cell (DC) subset composition, which also 
exhibit age-related changes. The aim of this study was to examine influence of 
aging on: i) Albino Oxford (relatively resistant to EAE) and Dark Agouti 
(susceptible to EAE) rat development of EAE and ii) their splenic conventional 
(OX62+) DC population in respect to its subset composition and expression of 
mRNAs for proinflammatory and immunosuppressive cytokines. We used 3-
month-old (young) and 26-month-old (aged) rats of AO and DA strain. The 
rats were immunized for EAE with rat spinal cord homogenate in complete 
Freund’s adjuvant and clinical course of the disease was followed. Fresh 
OX62+DCs were examined for the expression of CD4 (using flow cytometry) 
and genes encoding cytokines influencing DC activation/maturation (TNF-α 
and IL-6) using RT-PCR. Additionally, in vitro lipopolysaccharide (LPS) 
activated/matured DCs were examined for the expression of genes encoding 
cytokines controlling Th1/Th17 cell polarization using RT-PCR. With aging, 
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AO rats became more susceptible, whereas DA rats largely lose their 
susceptibility to the induction of EAE. In AO rats aging shifted CD4+:CD4- 
DC ratio towards CD4- cells, producing large amount of proinflammatory 
cytokines, whereas in DA rats CD4+:CD4- DC ratio remained stable with 
aging. In fresh DCs from rats of both the strains the expression of TNF-α 
mRNA increased with aging, whereas that of IL-6 mRNA decreased and 
increased in DCs from AO and DA rats, respectively. Following in vitro LPS 
stimulation OX62+ DCs from aged AO rats up-regulated the expression of 
mRNA for IL-23p19 (specific subunit of IL-23; crucial for sustained IL-17 
production) and IL-1β (positive IL-17 regulator), whereas down-regulated the 
expression of IL-10 (negative IL-17 regulator) when compared with young 
strain-matched rats. In DA rats aging incresed IL-23p19 mRNA expression in 
LPS-stimulated DCs, whereas exerted the opposing effects on the expression of 
mRNAs for IL-10 and IL-1β compared to AO rats. Irrespective of the rat strain, 
aging did not influence mRNA expression for IL-12p35 (driving Th1 
polarization) in DCs. Overall, results suggest role of changes in the expression 
of genes encoding proinflammatory and immunosuppressive cytokines in 
development of age-related alterations in rat susceptibility to EAE induction.  
  Key words: Aging, Cytokine gene expression, Dendritic cells, 
Experimental autoimmune encephalomyelitis, Rat strain differences  
 
 
INTRODUCTION 
Dendritic cells (DCs) have been recognized as highly potent antigen presenting cells 
(APCs). These cells have important role within immune system, being not only initiators, but 
also regulators of immune response (HART, 1997; BANCHEREAU and STEINMAN, 1998). In 
unperturbed tissues, there are primarily immature DCs, which are specialized for up taking 
environmental antigens by different routes and processing them (CELLA et al., 1997; 
BANCHEREAU et al., 2000). It is supposed that they are involved in maintenance of tolerance 
(CELLA et al., 1997; BANCHEREAU et al., 2000). Upon encountering antigen in the presence of 
inflammation and danger signals (dying cells, microorganisms, proinflammatory cytokines), DCs 
undergo complex maturation/activation process (BANCHEREAU and STEINMAN, 1998; REISE 
SOUSA, 2006). This enables them to prime naive T cells, and initiate primary immune response 
(BANCHEREAU et al., 2000). In addition, they produce specific constellation of cytokines, which 
is decisive for T cells polarization into different subsets of Th (Th1, Th2, Th17) effector cells 
(KAPSENBERG, 2003; PULENDRAN, 2005; FEILI-HARIRIR et al., 2005; REIS E SOUSA, 2006). 
Considering origin, morphology, phenotype, maturational and functional capacity, DCs represent 
extremely heterogeneous population (NAIK, 2008; SATHE and SHORTMAN, 2008). In rat secondary 
lymphoid organs, at least three different subsets of DCs: CD4+ and CD4- conventional DCs 
(cDCs) expressing CD103 (αox62 integrin subunit; recognised by MRC OX62 monoclonal 
antibody) and plasmacytoid DCs (pDCs) can be distinguished (VOISINE et al., 2002; HUBERT et 
al., 2004). It has been demonstrated that CD4- DCs (OX62+CD11b+CD4-) have myeloid 
morphology, produce large amounts of the proinflammatory cytokines and induce a Th1 
response in co-culture with allogeneic CD4+ T cells (VOISINE et al., 2002). On the other hand, 
the CD4+ DCs (OX62+CD11b+CD4+) have more heterogeneous morphology than CD4- DCs, 
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induce CD4+ and CD8+ cell proliferation, produce low levels of proinflammatory cytokines and 
are capable of induction of both Th1 and Th2 responses (VOISINE et al., 2002).  
It is noteworthy that adult inbred rodent strains differs greatly according to 
susceptibility to the induction of experimental autoimmune encephalomyelitis (EAE), ranging 
from almost complete resistant to extremely high susceptible (MILJKOVIC and MOSTARICA 
STOJKOVIC, 2006). Furthermore, as sensitivity to autoimmune diseases, including EAE 
development, is shown to be at least partly determined by DCs functional capacity (WALDNER et 
al., 2004; REIS E SOUSSA, 2006), a predisposition of experimental animals for development of 
EAE could be associated with strain-dependent specificities of these cells (YANG and HOU, 
2006). Moreover, in the rat, the proportion of distinct splenic DC subsets is strain-dependent 
(FOURNIE et al., 2001; HUBERT et al., 2006), and highly predictive for strain-dependent 
susceptibility to organ specific autoimmune diseases (HUBERT et al., 2006).   
Aging is associated with progressive immune system changes, which involve all types 
of immune cells (NIKOLICH-ZUGICH, 2005; GRUVER et al., 2007; SHAW et al., 2010; SOLANA et 
al., 2012). The data on age-associated DC alterations, and, in particular, those affecting Th-
polarizing cytokine gene expression, origin mainly from studies in mice and humans, and are 
largely inconsistent (AGRAWAL et al., 2008; SHAW et al., 2010; AGRAWAL et al., 2012; GUPTA, 
2014). At clinical level, age-related immune changes manifest as: i) increased susceptibility to 
infections and reduced response to vaccination, ii) altered incidence of autoimmune diseases 
(VOLLMER and WAXMAN, 1991; CASTLE et al., 2000; LESLIE and DELLI CASTELLI, 2004) and iii) 
increased incidence of cancer (CASTLE et al., 2000). Although incidence of many diseases 
increases with aging, it is not the case with the incidence of multiple sclerosis, a prototype of 
Th1/Th17-mediated organ-specific autoimmune disease (FLETCHER et al., 2010), and diabetes 
mellitus type I (LESLIE and DELLI CASTELLI, 2004). A prominent feature of multiple sclerosis is 
its high (50%) incidence of onset between the ages of 20 and 40 years. Onset in persons younger 
than 10 and older than 50 accounts for less than 5% of cases (VOLLMER and WAXMAN, 1991; 
FAROOQI et al., 2010). This is suggestive of age-related restriction of multiple sclerosis clinical 
expression (VOLLMER and WAXMAN, 1991; FAROOQI et al., 2010). Emerging clues suggest that 
DC dysregulation might be involved in the development of various autoimmune disorders 
(LUDEWIG et al., 2001; MEHLING and BEISSERT, 2003; HARDIN, 2005). It has been reported that 
age-related genetic factors not only influence the risk for development of autoimmune diseases, 
but also their clinical presentation and the rate of progression (LESLIE and DELLI CASTELLI, 
2004). Therefore it may be hypothesized that age-related changes in DC gene expression 
contribute to alterations in susceptibility to autoimmune disease induction in aged rodent 
(KALLEN and NILSSON, 1989; LUDOWYK et al., 1993; DITAMO et al., 2005; TARJANYJ et al., 
2009).  
The influence of aging on rodent susceptibility to development of EAE, the most 
commonly used experimental model of multiple sclerosis, is shown to be strain-dependent 
(KALLEN and NILSSON, 1989; LUDOWYK et al., 1993; DITAMO et al., 2005; TARJANYJ et al., 
2009).  
Having in mind all aforementioned, we designed the present study to investigate 
influence of aging on: i) EAE development in two rat strains characterized by differential 
susceptibility to the induction of this disease in adult ages and ii) splenic DCs in respect of the 
subset composition and proinflammatory and immunosuppressive cytokine gene expression. For 
this purpose we chose 3-month-old (young) and 26-month-old (aged) Albino Oxford (AO) and 
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Dark Agouti (DA) inbred rats, which are relatively resistant and susceptible to induction of 
several Th1/Th17-mediated autoimmune diseases, including EAE, respectively (DIMITRIJEVIĆ et 
al., 2001; MILJKOVIC and MOSTARICA STOJKOVIC, 2006; MILJKOVIC et al., 2006).  
 
MATERIALS AND METHODS 
 
Animals 
In this study we used 3- and 26-month-old female AO and DA rats, bred in the 
Immunology Research Centre „Branislav Janković“ animal facility. We performed two sets of 
experiments. In the first set of experiments we immunized rats for induction of EAE and 
monitored them for clinical signs of disease. In the second set of experiments, we analyzed 
phenotypic characteristics and/or cytokine mRNA expression in freshly isolated and cultivated 
DCs. Rats showing evident signs of illness, tumors or splenomegaly at autopsy were excluded 
from the study. All animals were handled in accordance with the Directive 2010/63/EU of the 
European Parliament and of the Council on the protection of animals used for scientific purposes 
(revising Directive 86/609/EEC). The experimental protocol was approved by the Institutional 
Experimental Animal Committee. 
 
Reagents and antibodies 
The culture medium consisted of RPMI 1640 medium (Sigma-Aldrich Chemie GmbH, 
Taufkirchen, Germany) supplemented with 2 mM L-glutamine (Serva, Heidelberg, Germany), 1 
mM sodium pyruvate (Serva), 100 units/ml penicillin (ICN, Costa Mesa, CA, USA), 100 µg/ml 
streptomycin (ICN) and 10% fetal calf serum (FCS) (Gibco, Grand Island, NY, USA) was used. 
Collagenase D was obtained from Roche Diagnostics (Meylan, France). The complete Freund's 
adjuvant (CFA), density gradient medium Optiprep™, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), lipopolysaccharide from Escherichia coli (LPS) and 
sodium azide were purchased from Sigma Aldrich Chemie GmbH. Ethylenediamine-tetraacetic 
acid (EDTA) and bovine serum albumin (BSA) were obtained from Fluka AG (Chemie) GmbH 
(Buchs SG, Switzerland). Suspension of Bordatella pertussis cells was obtained from Institute of 
Virology, Vaccines and Sera “Torlak” (Belgrade, Serbia).  
In addition, we used the following mouse anti-rat monoclonal antibodies (mAbs): 
fluorescein-isothiocyanate (FITC)-conjugated anti-CD4 (clone OX-38) and FITC/biotin-
conjugated anti-CD11b (clone WT.5) were purchased from BD Biosciences Pharmingen (San 
Diego, CA, USA) and phycoerithrin (PE)-conjugated anti-αOX-62 integrin subunit (anti-OX62; 
clone OX-62), purchased from AbD Serotec (Oxford, UK). Streptavidin-PerCP from BD 
Biosciences Pharmingen was used as secondary step reagent. The appropriate isotype controls 
were also purchased from BD Biosciences Pharmingen.  
 
Induction and clinical assessment of EAE 
EAE was induced by an intracutaneous injection (into the left hind foot) of 0.1 ml of an 
emulsion containing rat spinal cord homogenate (20 mg/rat) in CFA (0.3 mg Mycobacterium 
tuberculosis/rat). In addition, rats received an injection of 9 x 109 Bordetella pertussis cells 
subcutaneously.  
The monitoring of rats for clinical signs of the disease was conducted daily. Clinical 
signs were graded as follows: 0- no clinical signs, 0.5 - partial loss of tail tonicity, 1- paralysis of 
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tail, 2- paraparesis of hind limbs, 3- paraplegia and 4- tetraplegia or moribund state. The clinical 
signs are presented as a maximum clinical score reflecting the overall severity of disease.  
Isolation and preparation of DCs  
Spleens, dissected from rats euthanized by exposure to increasing doses of CO2, were 
minced and digested in 2 mg/ml collagenase D in RPMI/2% FCS for 30 min at 37°C. After 
washing in PBS/2% FCS, cells were resuspended in RPMI/0.04% EDTA and mixed with 
Optiprep™ (3:1 v/v) to give a 15% solution (ρ=1.085 g/ml). This cell suspension (4 ml) was 
overlaid with 5 ml of 11.5% Optiprep™ (ρ=1.068 g/ml) and 2 ml RPMI/0.02% EDTA and 
centrifuged at 600 g for 15 min at 4°C without braking. The low density cell fraction (LDF) at 
the interface of the top two layers was collected and washed. These cells were used for 
phenotypic analysis or were subjected to immunomagnetic separation in order to isolate OX62+ 
cells. 
Next, OX62+ cells were separated from splenic LDF using immunomagnetic cell 
separation technique and anti-rat OX62 microbeads (Miltenyi Biotec, Teterow, Germany). The 
separation procedure was conducted according to manufacturer’s instructions (Miltenyi Biotec). 
Briefly, after incubation of LDF with anti-rat OX62 microbeads (4°C, 15 min), positive selection 
was performed on magnetic cell separation column by using QuadroMACS magnet (Miltenyi 
Biotec). The purity of DCs obtained in this manner was up to 85% (as shown by staining with 
FITC--conjugated anti-CD11b).  
Next, magnetically sorted OX62+ cells were analysed for cytokines expression or 
cultured in 24-well plates (1x106 cells/ml per well) in the RPMI/10% FCS with LPS (1 µg/ml) or 
without LPS. After 16-18 h cells were collected and used for analyses of cytokines expression.   
 
Flow cytometry analysis (FCA) of surface markers 
For phenotypic analysis, LDF cells (1x105 cells per sample) were incubated with 
fluorochrome-labeled mAbs (direct labeling) and/or with unlabeled Abs (indirect labeling) for 30 
min. Cells subjected to indirect labeling were incubated with second step reagent for further 30 
min. All incubations were performed in the dark on ice. After incubations, cells were washed 
three times with PBS/2% FCS/0.1% sodium azide. Non-specific isotype-matched controls were 
used for each fluorochrome type to define background staining, while dead cells and debris were 
excluded from analysis by selective gating based on anterior and right-angle scatter. The 
percentage of positive cells was determined by using a FACScan flow cytometer (Becton 
Dickinson, Mountain View, CA, USA) and post-acquisition data analysis was performed with 
FlowJo software, v.7.8. (Three Star, Inc., Ashland, OR, USA). 
 
Real time PCR analysis of cytokine mRNA expression  
Total RNA was isolated from 1x105 fresh and cultured OX62+ DCs by using the ABI 
Prism 6100 Nucleic Acid PrepStation (Applied Biosystems, Foster City, CA, USA) and Total 
RNA Chemistry (Applied Biosystems). Reverse transcription was performed with High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems), and 5 µl of cDNA was used for real-
time PCR. Triplicate 25 µl reactions were ran under Applied Biosystems 7500 universal cycling 
conditions. Gene Expression Master Mix and commercial TaqMan Gene Expression Assays for 
rat TNF-α (Rn99999017_m1), IL-10 (Rn00563409_m1), IL-12a (Rn00584538_m1), IL-23a 
(Rn00590334_g1), IL-6 (Rn99999011_m1), IL-1β (Rn99999009_m1) and hypoxanthine 
phosphoribosyltransferase 1 (HPRT 1) (Rn01527840_m1) were obtained from Applied 
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Biosystems. All procedures were performed according to manufacturer’s instructions. Input 
cDNA was normalized to housekeeping gene (HPRT 1) as it displayed an optimal stability 
among various samples tested. Quantitative differences in gene expression levels were assessed 
using Applied Biosystems SDS software (v 1.4.0.) and 2-∆∆Ct method. 
 
Statistical analysis 
To assess significances between groups, we used: Student's unpaired t-test for testing 
the influence of aging on fresh OX62+ DCs subset distribution and Mann-Whitney U test for 
testing the influence of aging on OX62+ DCs cytokine mRNA expression. All analyses were 
performed using SPSS version 18.0 software. Differences were considered to be significant 
when p<0.05.  
 
 
RESULTS  
Aging alters resistance/susceptibility to EAE induction in AO and DA rats 
In the first set of experiments, we examined the influence of aging on EAE 
development. Our results showed that, with aging, relatively resistant AO rats became more 
susceptible to EAE induction (Table 1). Namely, differently from young AO rats, which did not 
express observable symptoms of the disease, the incidence of EAE raised to 60% in aged rats of 
this strain (Table 1). The diseased rats exhibited mild clinical signs judging by maximum clinical 
score (Table 1). Contrary to AO rats, DA rats, which were highly susceptible to the induction of 
EAE in young age, became more resistant to the disease induction with aging (Table 1). 
Specifically, there was no significant difference in the disease onset, but aged DA exhibited a 
lower incidence of the disease and lower maximum clinical score, when compared with strain-
matched young animals (Table 1).   
 
Table 1. The effect of aging on experimental autoimmune encephalomyelitis (EAE) in Albino Oxford (AO) 
and Dark Agouti (DA) rats 
  
Incidence 
of EAE 
Day of onset 
(mean±SEM) 
Maximal clinical 
score 
AO Young 0/14 (0%) - 0 
 Aged 6/10 (60%) 10.3±1.36 2 
DA Young 9/9 (100%) 11.67±0.41 4 
 Aged 3/11 (27.3%) 11.33±0.41 2 
 
Influence of strain and aging on splenic OX62+CD11b+ DC subset composition and expression 
of mRNAs for cytokines influencing Th1/Th17 polarization 
Next, we examined the influence of aging on the relative proportion of CD4+ and CD4- 
cells within OX62+ splenic DC population from AO and DA rats, as well as on their expression 
of cytokine mRNAs.  
 
Aging exhibits strain-specific influence on rat splenic OX62+CD11b+ DC subset composition  
In fresh OX62+CD11b+ DC population from young AO rats, CD4+ cells represented 
the predominant cell type (Figure 1). However, comparing with OX62+CD11b+ DCs from 
young AO rats, in this cell population from aged rats of the same strain, the relative proportion of 
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CD4+ cells was reduced (p<0.001), whereas that of CD4- cells was increased  (p<0.001), so that 
the latter cells become predominant (Figure 1).   
On the other hand, in DA rats, CD4- subset was the predominant subset in fresh splenic 
OX62+CD11b+ DC population of young animals, and aging did not significantly influence the 
relative representation of these cells within OX62+CD11b+ DCs (Figure 1). 
 
 
 
Figure 1. Strain-specific influence of aging on rat splenic OX62+ DC subsets composition 
The figure shows percentages of CD4+ and CD4- cells within OX62+CD11b+ DCs from young 
and aged rats of Albino Oxford (AO) and Dark Agouti (DA) strains. (A) The flow cytometric 
contour histograms represent the expression of CD4 and CD11b on gated OX62+ DCs from 
splenic low density fraction from (left) young and (right) aged rats from (upper) AO and (lower) 
DA strains. (B) The stacked bar graph indicates the percentage of CD4+ and CD4- 
OX62+CD11b+ DCs. Results are expressed as mean ± SEM (n=6);  a CD4- DCs from aged vs. 
CD4- DCs from young strain-matched rats; b CD4+ DCs from aged vs. CD4+ DCs from young 
strain-matched rats; ***p<0.001. The figure indicates results from a single experiment. Similar 
data were obtained in three independent experiments. 
 
 
Aging exhibits strain-specific influence on the expression of mRNAs for TNF-α and IL-6 in fresh 
OX62+ splenic DCs 
Considering putative importance of the steady-state immature DCs in lymphoid organs 
for the maintenance of peripheral tolerance (WILSON et al., 2003), we examined the expression of 
mRNAs for cytokines that might influence their maturational status.  
We found that fresh OX62+ DCs from aged AO rats expressed increased amount 
(p<0.05) of mRNA for TNF-α and decreased (p<0.05) that for IL-6 when compared with strain-
matched young rats (Figure 2). On the other hand, in the same cells of aged DA rats, the 
expression of mRNAs for both TNF-α and IL-6 mRNAs was augmented (p<0.05 and p<0.01, 
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respectively) relative to that of corresponding mRNA in OX62+ DCs from strain-matched young 
animals (Figure 2).   
 
 
Figure 2. Strain-specific influence of aging on the expression of mRNAs for TNF-α and IL-6 in 
fresh OX62+ splenic DCs 
The bar graphs represent fold change in mRNA expression for TNF-α and IL-6 in 
fresh splenic OX62+ DCs from (left) AO and (right) DA aged rats relative to those 
from strain-matched young rats. HPRT was selected as the housekeeping gene to 
normalize for input cDNA variation as it displayed an optimal stability in our 
experimental system. The data are presented as mean ± SEM (n=6); *p<0.05; 
**p<0.01. The figure indicates results from a single experiment. Similar data were 
obtained in three independent experiments.  
 
Strain-specific influence of aging on the expression of mRNA for immunostimulatory and 
immunosuppressive cytokines in LPS-stimulated DCs  
Since mature/activated DCs are shown not only to initiate immune response, but also to 
influence Th polarization (KAPSENBERG, 2003), we investigated the influence of aging on 
OX62+ DCs expression of mRNAs for cytokines driving/influencing Th17 and/or Th1 
polarization. 
Our results showed that in the presence of LPS, a Toll like receptor (TLR4) agonist that 
acts as maturation factor, OX62+ DCs from aged AO rats expressed greater (p<0.001) amount of 
mRNA for IL-23p19, specific subunit of the heterodimeric IL-23 cytokine, than the 
corresponding cells from young strain-matched rats (Figure 3). However, these cells exhibited 
lower (p<0.001) expression of mRNA for immunosuppressive IL-10 cytokine, which was 
accompanied with a greater (p<0.001) expression of IL-1β mRNA compared with young strain-
matched rats (Figure 3). Unlike LPS-stimulated OX62+ DCs from aged AO rats, the 
corresponding cells from DA rats exhibited increased expression of mRNAs for IL-23p19 
(p<0.001) and IL-10 (p<0.001), whereas the expression of IL-1β mRNA was diminished 
(p<0.05) when compared with young strain-matched rats (Figure 3). Finally, irrespective of rat 
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strain there was no significant difference in the expression of mRNA for IL-12p35, a subunit of 
heterodimeric Th1 polarizing IL-12 (MACATONIA et al., 1995; BECKER et al., 2005), between 
LPS-stimulated OX62+ DCs from aged and young rats (data not shown). 
 
 
Figure 3. Strain-specific influence of aging on mRNA expression for IL-23p19, IL-10 and IL-1β 
in LPS-stimulated OX62+ DCs  
The bar graphs represent fold change in mRNA expression for IL-23p19, IL-10 and 
IL-1β in control (LPS-) OX62+ DCs from aged rats and LPS-stimulated (LPS+) 
OX62+ DCs from young and aged rats from (left) AO and (right) DA rats relative to 
those from young strain-matched control rats. HPRT was selected as the housekeeping 
gene to normalize for input cDNA variation as it displayed an optimal stability in our 
experimental system. The data are presented as mean ± SEM (n=6); *p<0.05; 
**p<0.01; ***p<0.001. The figure indicates results from a single experiment. Similar 
data were obtained in three independent experiments.  
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It should be mentioned, that quite expectably, as rat DCs put in culture medium alone 
exhibit significant degree of “spontaneous activation/maturation” (VREMEC et al., 2011), the 
expression of cytokine mRNA was not always greater in DCs from LPS-stimulated cultures 
when compared to that in control (LPS- cultures) (Figure 3). 
 
DISCUSSION 
As expected from the previous studies (MOSTARICA-STOJKOVIC et al., 1982; STOSIC-
GRUJICIC et al., 2004), differently from young AO rats, all young DA rats developed clinical 
signs of EAE. On the other hand, for the first time to our best knowledge, we showed that 
susceptibility of both AO and DA rats to induction of EAE changes with aging, so it increases in 
AO rats and decreases in DA rats. This is consistent with earlier reports indicating that in 
rodents, aging influences susceptibility to EAE development in a strain-specific manner (KALLEN 
and NILSSON, 1989; LUDOWYK et al., 1993; DITAMO et al., 2005; TARJANYI et al., 2009).  This 
phenomenon can be related to the data demonstrating that age-related genetic factors influence 
not only the risk for development of autoimmune diseases, but also their clinical presentation and 
the rate of progression (LESLIE and DELLI CASTELLI, 2004). It is also consistent with findings 
indicating that genetic component has a strong impact on aging process (LARBI et al., 2008). 
However, considering that all types of immune cells suffer age-related changes (GRUVER et al., 
2007; SHAW et al., 2010), our findings inevitably imposed question which type/s is/are 
responsible for the age-related changes in the development of EAE. Given that DCs are 
considered to be key players in immunity and tolerance (BANCHEREAU and STEINMAN, 1998; 
STEINMAN et al., 2003), we focused on these cells. 
Confirming the previous studies indicating that DC subset composition correlates with 
the rat susceptibility to autoimmune disease induction and Th polarization (FOURNIE et al., 2001; 
HUBERT et al., 2006), we found that, opposing to OX62+CD11b+ DC population from young 
AO rats, this population from DA rats exhibited the predominance of CD4- cells. These cells 
produce large amount of proinflammatory cytokines (VOISINE et al., 2002; HUBERT et al., 2006), 
and the increase in their proportion is associated with a greater susceptibility to Th1/Th17-
mediated diseases (FOURNIE et al., 2001; HUBERT et al., 2006). Considering these findings, the 
age-related shift in CD4+:CD4- subset ratio toward CD4- subset in AO rats could be linked with 
a greater susceptibility of aged rats of this strain to EAE. On the other hand, despite the age-
related changes in EAE development in DA rats, we failed to observe any changes in 
OX62+CD11b+ DC subset composition. This could suggest that, differently from AO rats, in 
DA rats rather age-related changes at cellular level than those at population level influence 
susceptibility to EAE induction. The former might reflect age-related both intrinsic (AGRAWAL et 
al., 2007; PANDA et al., 2010) and extrinsic DC changes (CHELVARAJAN et al., 2005; MÜNZ et al., 
2005; LIAO et al., 2007) affecting their capacity to produce polarizing cytokines. Alternatively, it 
may be also assumed that alterations in the abundance of pDCs, which is also shown to be strain 
dependent (HUBERT et al., 2006), contribute to the age-related changes in susceptibility of DA 
rats to EAE induction.  
Next, we analyzed the expression of mRNAs for TNF-α and IL-6 in fresh (presumably 
steady-state) OX62+ DCs, which are: i) supposed to be phenotypically and functionally 
immature, and ii) suggested to be involved in maintaining of tolerance (WILSON et al., 2003). In 
agreement with the age-related increase in the basal production of proinflammatory TNF-α 
(FRANCESCHI et al., 2000; GOMEZ et al., 2006; VASTO et al., 2007), which exerts a pro-activating 
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influence on DCs, acting in an autocrine manner (MORRISON et al., 2003; SLOBODIN et al., 2009), 
we found the enhanced expression of TNF-α in OX62+ DCs from rats from both strains 
comparing with the corresponding cells from young strain-matched rats. Differently from TNF-
α, aging had differential impact on the expression of mRNA for IL-6, which is shown to 
stimulate DC maturation (JONULEIT et al., 1997), in fresh OX62+ DCs from genetically distinct 
organisms. Namely, comparing with fresh OX62+ DCs from strain-matched young rats, the 
expression of IL-6 mRNA in the corresponding cells from aged DA was enhanced, whereas in 
those from AO rats was diminished. Therefore, it may be assumed that aging differentially 
affects maturational status of DCs from AO and DA rats. This is particularly relevant in the light 
of data indicating that the ability of the DC to induce tolerance is highly dependent on the stage 
of their maturation (REIS E SOUSSA, 2006).  Furthermore, to explore capacity of 
activated/mature OX62+ DCs to produce cytokines driving/influencing Th1 and Th17 
polarization, we examined the expression of mRNAs for relevant cytokines in these cells 
following LPS stimulation in vitro. We found that in LPS-stimulated OX62+ DCs from aged rats 
of both the strains the expression of IL-23p19 gene was augmented when compared with the 
corresponding cells from young strain-matched rats. However, differently from the expression of 
IL-23p19 mRNA, the expression of mRNA for IL-10, which is shown to be negative regulator of 
Th17 production (CORSETTI et al., 2013), was differentially affected by aging in LPS-stimulated 
OX62+ DCs from AO and DA rats. Namely, the expression of this mRNA in LPS-stimulated 
OX62+ DCs from DA rats increased with aging, whereas in these cells from AO rats it showed a 
prominent age-related decrease. Furthermore, given that endogenous IL-10 constrains Th17 cell 
development through down-regulation of IL-1β production by DCs (WILKE et al., 2011), the age-
associated changes in IL-1β mRNA expression in LPS-stimulated OX62+ DCs from AO and DA 
rats were fully consistent with the changes in their expression of IL-10 mRNA. Thus, our 
findings strongly suggest that aging differentially affects Th-polarizing capacity of the activated 
DCs from AO and DA rats, and therefore, possibly their susceptibility to EAE. 
Finally, although we failed to observe any significant changes in IL-12p35 mRNA 
expression in either AO or DA rats, the differential effect of aging on Th1 driving capacity of 
DCs from these strains could not be completely ruled out. Namely, it may assumed that in aged 
animals some strain-specific IL-12 independent factors (e.g. increased CD40 surface density, 
altered expression of other members of the IL-12 family or alterations in IL-12-independent 
CD27/CD70 axis component) could contribute to alterations in Th1 polarizing capacity of DC. 
This will be matter of our further studies.  
Overall, our study supports notion that alterations in gene expression contribute to age-
related risk for autoimmune disease onset, as well as to the severity of their clinical 
manifestations (LESLIE and DELLI CASTELLI, 2004). In addition, it points that age-related 
alterations in expression of genes encoding proinflammatory and immunosuppressive cytokines 
in DCs could contribute to risk for development of autoimmune diseases.   
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Izvod 
 Eksperimentalni autoimunski encefalomijelitis (EAE) je animalni model multiple 
skleroze i prototip autoimunske bolesti posredovane Th1/Th17 limfocitima. Pokazana je sojna- i 
uzrastna- zavisnost razvoja ove bolesti kod pacova kao i fenotipskih i funkcijskih promena 
dendritskih ćelija (DC) kod miša. Cilj rada je bio da se ispita uticaj starenja na: i) osetljivost AO 
i DA pacova na razvoj EAE i ii) odnos CD4+:CD4- subpopulacija OX62+ DC u slezini i njihovu 
ekspresiju iRNK za citokine koji utiču na polarizaciju CD4+ T-limfocita u ćelije Th1 i Th17 
fenotipa. Starenjem AO pacovi postaju osetljiviji, dok se kod DA smanjiuje podložnost razvoju 
EAE. U populaciji DC starih AO pacova je nađeno povećanje zastupljenosti CD4- ćelija 
(sintetišu velike količine proinflamatornih citokina), dok se kod DA pacova odnos CD4-:CD4+ 
ćelije nije menjao. Povećana ekspresiju iRNK za TNF-α je nađena u svežim DC starih pacova 
oba soja, dok je ekspresija iRNK za IL-6 u DC bila smanjena kod AO pacova, a povećana kod 
DA pacova. Nakon stimulacije LPS-om, ekspresija iRNK za IL-23p19 i IL-1β je bila veća u DC 
starih nego mladih AO životinja, dok je ekspresija iRNK za IL-10 bila manja. Kod DA pacova 
starenje je povećalo ekspresiju iRNK za IL-23p19, dok je na ekspresiju iRNK za IL-1β i IL-10 
imalo suprotan efekat u odnosu na AO pacove. Rezultati pokazuju da starenje, u zavisnosti od 
soja, različito utiče na razvoj EAE i sugeriše da se ovo može pripisati različitom uticaju na 
ekspresiju gena za citokine koji utiču na polarizaciju CD4+ limfocita u Th17 ćelije.  
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